keyword
https://read.qxmd.com/read/38541161/apraxia-patterns-for-the-differentiation-between-alzheimer-s-disease-and-frontotemporal-dementia-variants
#1
JOURNAL ARTICLE
Georgios Papadopoulos, Dimitrios Parissis, Anna Gotzamani-Psarrakou, Panagiotis Ioannidis
Background and Objectives : Despite the increasing use of biomarkers, differentiation between Alzheimer's disease (AD), behavioral variant Frontotemporal Dementia (bvFTD), and Primary Progressive Aphasia (PPA) remains a challenge. Apraxia is a supportive feature for diagnosing AD but is underrepresented in other dementia types. Herein, we investigated the presence and characteristic profiles of limb, verbal, and non-verbal apraxia in three major dementia types. Materials and Methods : Test for Upper Limb Apraxia (TULIA) and Apraxia Battery for Adults-2 (ABA-2) were administered in patients with AD (n = 22), bvFTD (n = 41), and PPA (n = 22), with 20 individuals serving as healthy controls (HC)...
March 6, 2024: Medicina
https://read.qxmd.com/read/38540709/astrocytes-the-stars-in-neurodegeneration
#2
REVIEW
Katarina Stoklund Dittlau, Kristine Freude
Today, neurodegenerative disorders like Alzheimer's disease (AD), Parkinson's disease (PD), frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) affect millions of people worldwide, and as the average human lifespan increases, similarly grows the number of patients. For many decades, cognitive and motoric decline has been explained by the very apparent deterioration of neurons in various regions of the brain and spinal cord. However, more recent studies show that disease progression is greatly influenced by the vast population of glial cells...
February 28, 2024: Biomolecules
https://read.qxmd.com/read/38522237/involvement-of-cb-1-and-cb-2-receptors-in-neuroprotective-effects-of-cannabinoids-in-experimental-tdp-43-related-frontotemporal-dementia-using-male-mice
#3
JOURNAL ARTICLE
Claudia Gonzalo-Consuegra, Irene Santos-García, Laura García-Toscano, Raquel Martín-Baquero, Carmen Rodríguez-Cueto, Matthias B Wittwer, Pawel Dzygiel, Uwe Grether, Eva de Lago, Javier Fernández-Ruiz
BACKGROUND: The elevation of endocannabinoid levels through inhibiting their degradation afforded neuroprotection in CaMKIIα-TDP-43 mice, a conditional transgenic model of frontotemporal dementia. However, which cannabinoid receptors are mediating these benefits is still pending to be elucidated. METHODS: We have investigated the involvement of the CB1 and the CB2 receptor using chronic treatments with selective ligands in CaMKIIα-TDP-43 mice, analysis of their cognitive deterioration with the Novel Object Recognition test, and immunostaining for neuronal and glial markers in two areas of interest in frontotemporal dementia...
March 23, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38494763/communicative-impairment-and-its-neural-correlates-in-alzheimer-s-disease-and-frontotemporal-dementia
#4
JOURNAL ARTICLE
Alexa Haeger, Janka Muising, Sandro Romanzetti, Bruno Fimm, Oliver Matz, Jörg B Schulz, Stefan Heim, Kathrin Reetz
OBJECTIVE: Communication skills can deteriorate in neurodegenerative diseases such as Alzheimer's disease (AD) and frontotemporal dementia (FTD); however, their clinical assessment and treatment in patient care can be challenging. In the present study, we aimed to quantify the distinctive communication resources and barriers reported by patients and their relatives in AD and FTD and associated these communicative characteristics with clinical parameters, such as the degree of cognitive impairment and atrophy in language-associated brain areas...
March 2024: Brain and Behavior
https://read.qxmd.com/read/38450645/genetic-and-in-silico-analysis-of-indian-sporadic-young-onset-patient-with-amyotrophic-lateral-sclerosis
#5
JOURNAL ARTICLE
Saileyee Roychowdhury, Deepika Joshi, Vinay Kumar Singh, Mohammed Faruq, Parimal Das
Background : Amyotrophic lateral sclerosis (ALS) is an old onset devastating neurodegenerative disorder. Young-onset ALS cases especially sporadic ones who are between 25 and 45 years are rarely affected by the disease. Despite the identification of numerous candidate genes associated with ALS, the etiology of the disease remains elusive due to extreme genetic and phenotypic variability. The advent of affordable whole exome sequencing (WES) has opened new avenues for unraveling the disease's pathophysiology better...
March 7, 2024: Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
https://read.qxmd.com/read/38391708/high-frequency-language-therapy-with-semantic-feature-analysis-sfa-and-transcranial-direct-current-stimulation-tdcs-a-longitudinal-single-case-report-of-semantic-variant-of-primary-progressive-aphasia-svppa
#6
Katharina Strunk, Sabine Weiss, Horst M Müller
BACKGROUND: The goal of this study was to investigate whether the combination of semantic feature analysis (SFA) and transcranial direct current stimulation (tDCS) is effective in treating word retrieval in the semantic variant of primary progressive aphasia (svPPA) and how long the potential effects last. METHODS: A 56-year-old woman diagnosed with frontotemporal dementia (FTD) and svPPA participated in this longitudinal single-subject design. A total of four 2-week stimulation phases were conducted over a 14-month period, each of which was started depending on the participant's language performance...
January 27, 2024: Brain Sciences
https://read.qxmd.com/read/38328941/predictors-of-primary-care-psychological-therapy-outcomes-for-depression-and-anxiety-in-people-living-with-dementia-evidence-from-national-healthcare-records-in-england
#7
JOURNAL ARTICLE
Georgia Bell, Celine El Baou, Rob Saunders, Joshua E J Buckman, Georgina Charlesworth, Marcus Richards, Caroline Fearn, Barbara Brown, Shirley Nurock, Stuart Michael, Paul Ware, Natalie L Marchant, Elisa Aguirre, Miguel Rio, Claudia Cooper, Stephen Pilling, Amber John, Joshua Stott
BACKGROUND: Psychological therapies can be effective in reducing symptoms of depression and anxiety in people living with dementia (PLWD). However, factors associated with better therapy outcomes in PLWD are currently unknown. AIMS: To investigate whether dementia-specific and non-dementia-specific factors are associated with therapy outcomes in PLWD. METHOD: National linked healthcare records were used to identify 1522 PLWD who attended psychological therapy services across England...
February 8, 2024: British Journal of Psychiatry
https://read.qxmd.com/read/38286395/clinical-and-cortical-trajectories-in-non-fluent-primary-progressive-aphasia-and-alzheimer-s-disease-a-role-for-emotion-processing
#8
JOURNAL ARTICLE
Ramon Landin-Romero, Fiona Kumfor, Austin Ys Lee, Cristian Leyton, Olivier Piguet
OBJECTIVES: To examine the clinical trajectories and neural correlates of cognitive and emotion processing changes in the non-fluent/agrammatic (nfvPPA) and the logopenic (lvPPA) variants of primary progressive aphasia (PPA). DESIGN: Observational case-control longitudinal cohort study. SETTING: Research clinic of frontotemporal dementia. PARTICIPANTS: This study recruited 29 non-semantic PPA patients (15 nfvPPA and 14 lvPPA) and compared them with 15 Alzheimer's disease (AD) patients and 14 healthy controls...
January 28, 2024: Brain Research
https://read.qxmd.com/read/38256652/mild-cognitive-impairment-progression-and-alzheimer-s-disease-risk-a-comprehensive-analysis-of-3553-cases-over-203-months
#9
JOURNAL ARTICLE
Nevra Öksüz, Reza Ghouri, Bahar Taşdelen, Derya Uludüz, Aynur Özge
This study aimed to elucidate the long-term progression of mild cognitive impairment (MCI) within a comprehensive longitudinal dataset, distinguish it from healthy aging, explore the influence of a dementia subtype on this progression, and identify potential contributing factors. Patients with prodromal and preclinical cases underwent regular neuropsychological assessments utilizing various tools. The study included a total of 140 participants with MCI, categorized into Alzheimer's disease (AD) and non-AD subtypes...
January 17, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38165329/changes-in-digital-speech-measures-in-asymptomatic-carriers-of-pathogenic-variants-associated-with-frontotemporal-degeneration
#10
JOURNAL ARTICLE
Naomi Nevler, Sunghye Cho, Katheryn A Q Cousins, Sharon Ash, Christopher A Olm, Sanjana Shellikeri, Galit Agmon, Carmen Gonzalez-Recober, Sharon X Xie, Megan S Barker, Masood Manoochehri, Corey T Mcmillan, David J Irwin, Lauren Massimo, Laynie Dratch, Gayathri Cheran, Edward D Huey, Stephanie A Cosentino, Vivianna M Van Deerlin, Mark Y Liberman, Murray Grossman
BACKGROUND AND OBJECTIVES: Clinical trials developing therapeutics for frontotemporal degeneration (FTD) focus on pathogenic variant carriers at preclinical stages. Objective, quantitative clinical assessment tools are needed to track stability and delayed disease onset. Natural speech can serve as an accessible, cost-effective assessment tool. We aimed to identify early changes in the natural speech of FTD pathogenic variant carriers before they become symptomatic. METHODS: In this cohort study, speech samples of picture descriptions were collected longitudinally from healthy participants in observational studies at the University of Pennsylvania and Columbia University between 2007 and 2020...
January 23, 2024: Neurology
https://read.qxmd.com/read/38049965/behavioral-variant-frontotemporal-dementia-with-the-dominantly-affected-caudate-nucleus-in-18f-fp-cit-pet-ct
#11
JOURNAL ARTICLE
Yeongjoo Lee, Seonjeong Byun, Sae Jung Na
Frontotemporal dementia is a clinical syndrome that is characterized by a progressive deterioration in behavior, personality, and/or language, with relative preservation of memory, and its phenotype and molecular basis are heterogeneous. We present a case of a 62-year-old female patient who underwent 18F-FDG PET/CT and 18F-FP-CIT PET/CT for differential diagnosis of psychiatric disease and types of dementia. 18F-FDG PET/CT image showed a compatible finding for frontotemporal dementia, and 18F-FP-CIT PET/CT image showed dominantly decreased dopamine transporter activity in the bilateral caudate nucleus...
December 5, 2023: Clinical Nuclear Medicine
https://read.qxmd.com/read/38002991/pharmacogenomics-of-dementia-personalizing-the-treatment-of-cognitive-and-neuropsychiatric-symptoms
#12
REVIEW
Barbara Vuic, Tina Milos, Lucija Tudor, Matea Nikolac Perkovic, Marcela Konjevod, Gordana Nedic Erjavec, Vladimir Farkas, Suzana Uzun, Ninoslav Mimica, Dubravka Svob Strac
Dementia is a syndrome of global and progressive deterioration of cognitive skills, especially memory, learning, abstract thinking, and orientation, usually affecting the elderly. The most common forms are Alzheimer's disease, vascular dementia, and other (frontotemporal, Lewy body disease) dementias. The etiology of these multifactorial disorders involves complex interactions of various environmental and (epi)genetic factors and requires multiple forms of pharmacological intervention, including anti-dementia drugs for cognitive impairment, antidepressants, antipsychotics, anxiolytics and sedatives for behavioral and psychological symptoms of dementia, and other drugs for comorbid disorders...
November 6, 2023: Genes
https://read.qxmd.com/read/37949997/breakdown-of-category-specific-word-representations-in-a-brain-constrained-neurocomputational-model-of-semantic-dementia
#13
JOURNAL ARTICLE
Yury Shtyrov, Aleksei Efremov, Anastasia Kuptsova, Thomas Wennekers, Boris Gutkin, Max Garagnani
The neurobiological nature of semantic knowledge, i.e., the encoding and storage of conceptual information in the human brain, remains a poorly understood and hotly debated subject. Clinical data on semantic deficits and neuroimaging evidence from healthy individuals have suggested multiple cortical regions to be involved in the processing of meaning. These include semantic hubs (most notably, anterior temporal lobe, ATL) that take part in semantic processing in general as well as sensorimotor areas that process specific aspects/categories according to their modality...
November 10, 2023: Scientific Reports
https://read.qxmd.com/read/37880536/high-serum-uric-acid-levels-are-protective-against-cognitive-impairment-in-amyotrophic-lateral-sclerosis
#14
JOURNAL ARTICLE
Barbara Iazzolino, Maurizio Grassano, Cristina Moglia, Antonio Canosa, Umberto Manera, Rosario Vasta, Sara Cabras, Stefano Callegaro, Enrico Matteoni, Francesca Di Pede, Francesca Palumbo, Gabriele Mora, Andrea Calvo, Adriano Chiò
BACKGROUND: Uric acid (UA) has emerged as a factor that can modify cognitive function both in the general population and in people with neurodegenerative disorders. Since very few data are available concerning amyotrophic lateral sclerosis (ALS), we explored the correlation of UA levels and cognitive impairment in a large cohort of ALS patients. METHODS: We enrolled ALS patients consecutively seen at the Turin ALS expert center in the 2007-2018 period who underwent both cognitive/behavioral and UA evaluation at diagnosis...
October 25, 2023: Journal of Neurology
https://read.qxmd.com/read/37872794/behavioural-variant-frontotemporal-dementia-due-to-ccnf-gene-mutation-a-case-report
#15
Feng-Ling You, Gao-Fu Xia, Jing Cai
BACKGROUND: Frontal, temporal lobe dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal neurodegenerative diseases. Studies have found that CCNF mutations have been found in patients with familial and sporadic ALS and FTD. Behavioural variant frontotemporal dementia (bvFTD) is a clinical syndrome characterized by progressive deterioration of personality, social behaviour, and cognitive function, which is most closely related to genetic factors. As the early symptoms of bvFTD are highly heterogeneous, the condition is often misdiagnosed as Alzheimer's disease or psychiatric disorders...
2023: Current Alzheimer Research
https://read.qxmd.com/read/37807476/b-103-early-onset-frontotemporal-dementia-a-neuropsychological-case-study
#16
JOURNAL ARTICLE
Steven Greco, Robert Sica, Jasmin Sawhney, Amisha Rastogi
OBJECTIVES: A neuropsychological case review of Early-Onset Frontotemporal Dementia (FTD) utilizing the Meyers Neuropsychological Battery (MNB). FTD is a degeneration of brain nerve cells resulting in behavioral deterioration and other effects upon personality and brain functions. Due to early onset of FTD, diagnostic ambiguity is often the case. The current case was a patient referred by neurology to rule-out adult ADHD/LD. METHODS: The patient is a 51-year-old, Caucasian, right-handed male...
October 8, 2023: Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists
https://read.qxmd.com/read/37807144/a-40-assessment-of-dementia-with-lewy-bodies-in-a-patient-with-both-characteristic-and-atypical-features
#17
JOURNAL ARTICLE
Nikhil Banerjee, Cullen Hicks, Lealani Acosta
OBJECTIVE: Dementia with Lewy Bodies (DLB) is the second most common neurodegenerative dementia after Alzheimer disease (ad). Its heterogeneous presentation and overlapping features with other dementias result in frequent misdiagnosis, which can delay optimal management. The present case illustrates complex symptomology, comprehensive assessment, and diagnostic challenges in a patient with DLB. METHOD: A 64-year-old female presented to an academic medical center neurology clinic with rapid cognitive deterioration over the past 1...
October 8, 2023: Archives of Clinical Neuropsychology: the Official Journal of the National Academy of Neuropsychologists
https://read.qxmd.com/read/37719694/it-is-not-depression-a-case-report-of-a-37-year-old-firefighter-with-frontotemporal-dementia
#18
Fa'iza Abdullah, Anith Aqillah Abd Razak, Umi Kalsom Mohd Idris
A 37-year-old married, right-handed active firefighter presented to the primary care clinic with a self-report of difficulties in memorising and recalling information associated with declining work performance. Collaborative history-taking revealed that he also experienced emotional and social withdrawal, apathy, irritability and distractibility. He was initially diagnosed with major depressive disorder but showed no improvement with an antidepressant. This young man with no history of hereditary neurodegenerative disorder had further deterioration in cognitive function, predominantly executive behaviours, with progressive aphasia...
2023: Malaysian Family Physician
https://read.qxmd.com/read/37622054/tank-binding-kinase-1-mutation-as-a-rare-cause-of-frontotemporal-dementia-in-a-mexican-patient-the-first-case-report-in-a-tertiary-referral-hospital-in-mexico
#19
Humberto Estrada-Rodriguez, Daniel A Meza-Martinez, Marco Antonio Muñuzuri-Camacho, David Garcia-Romero, Isael Reyes-Melo
Frontotemporal dementia (FTD) is a heterogeneous condition characterized by changes in behavior, personality, and language resulting from degeneration of the frontal and/or temporal lobes. A wide spectrum of clinical syndromes and an overlap with different motor disorders make this entity challenging for clinicians, both in achieving a correct diagnosis and providing proper treatment. Despite the majority of cases being sporadic, FTD has a hereditary component, and more than 10 disease-causing genes have been identified...
August 2023: Curēus
https://read.qxmd.com/read/37462752/longitudinal-changes-in-qualitative-aspects-of-semantic-fluency-in-presymptomatic-and-prodromal-genetic-frontotemporal-dementia
#20
JOURNAL ARTICLE
Lize C Jiskoot, Esther van den Berg, Sascha A A M Laenen, Jackie M Poos, Lucia A A Giannini, Djaina D Satoer, Judy van Hemmen, Yolande A L Pijnenburg, Jet M J Vonk, Harro Seelaar
BACKGROUND: The semantic fluency test is one of the most widely used neuropsychological tests in dementia diagnosis. Research utilizing the qualitative, psycholinguistic information embedded in its output is currently underexplored in presymptomatic and prodromal genetic FTD. METHODS: Presymptomatic MAPT (n = 20) and GRN (n = 43) mutation carriers, and controls (n = 55) underwent up to 6 years of neuropsychological assessment, including the semantic fluency test...
July 18, 2023: Journal of Neurology
keyword
keyword
46163
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.